Hennion & Walsh Asset Management, Inc. Bridge Bio Pharma, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.06 Billion
- Q3 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 38,043 shares of BBIO stock, worth $969,335. This represents 0.05% of its overall portfolio holdings.
Number of Shares
38,043
Previous 39,099
2.7%
Holding current value
$969,335
Previous $990,000
2.22%
% of portfolio
0.05%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding BBIO
# of Institutions
296Shares Held
176MCall Options Held
8.64MPut Options Held
2.81M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$791 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$640 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$317 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$155 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.78B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...